SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001564590-17-019555
Filing Date
2017-10-17
Accepted
2017-10-17 16:47:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-1 vktx-s1_20171017.htm S-1 673645
2 EX-5.1 vktx-ex51_7.htm EX-5 22287
3 EX-23.1 vktx-ex231_6.htm EX-23 3978
4 GRAPHIC g201710170117302374811.jpg GRAPHIC 2494
5 GRAPHIC g201710170117299044810.jpg GRAPHIC 2494
6 GRAPHIC g201710170117302464812.jpg GRAPHIC 2494
7 GRAPHIC g201710170117327164659.jpg GRAPHIC 3305
8 GRAPHIC g201710170117377984660.jpg GRAPHIC 3305
  Complete submission text file 0001564590-17-019555.txt   721105
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-220992 | Film No.: 171141065
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences